Symbol="EVOK"
AssetType="Common Stock"
Name="Evoke Pharma Inc"
Description="Evoke Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of drugs for the treatment of gastroenterological diseases and disorders. The company is headquartered in Solana Beach, California."
CIK="1403708"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="420 STEVENS AVENUE, SUITE 370, SOLANA BEACH, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5783500"
EBITDA="None"
PERatio="None"
PEGRatio="-0.1"
BookValue="0.636"
DividendPerShare="0"
DividendYield="0"
EPS="-2.62"
RevenuePerShareTTM="0.88"
ProfitMargin="-2.859"
OperatingMarginTTM="-2.72"
ReturnOnAssetsTTM="-0.517"
ReturnOnEquityTTM="-4.085"
RevenueTTM="2900700"
GrossProfitTTM="2138300"
DilutedEPSTTM="-2.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.937"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.048"
PriceToBookRatio="1.033"
EVToRevenue="0.0648"
EVToEBITDA="0.195"
Beta="0.334"
num_52WeekHigh="5.96"
num_52WeekLow="1.372"
num_50DayMovingAverage="1.762"
num_200DayMovingAverage="2.276"
SharesOutstanding="3343100"
DividendDate="None"
ExDividendDate="None"
symbol="EVOK"
open="1.72"
high="1.74"
low="1.70"
price="1.70"
volume="4038.00"
latest_trading_day="2023-07-11"
previous_close="1.73"
change="-0.03"
change_percent="-1.7341%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="72"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="24780"
Change_recent_avg="-0.01"
Delta_recent_avg="0.17"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.73"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="1145"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_negative_thumbnail_id_2="1131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="679"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_positive_thumbnail_id_2="959"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
